Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) approved a single-injection, once-monthly maintenance regimen (200 mg/2 mL) of Omvoh (mirikizumab-mrkz) for ...

Omvoh now offers patients a simplified maintenance experience with one monthly injection, replacing the previous two-injection regimen Omvoh single-injection dosing ...

You can get FluMist for self-administration (called FluMist Home) by visiting the manufacturer’s website. You’ll need to complete four steps to order the vaccine: Provide your basic information, such ...

Now you can give yourself a flu vaccine at home. Should you try it? If you have a fear of needles and are nervous about getting the flu shot, you’re not alone. It’s estimated that up to 25% of adults ...

New LEQEMBI Companion TM program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who can provide patients with injection training, and an ...

If you have a fear of needles and are nervous about getting the flu shot, you’re not alone. It’s estimated that up to 25% of adults have a strong fear of needles. Enter FluMist, the nasal flu vaccine.

Novo Nordisk has agreed to buy Akero Therapeutics in a deal rising to a potential $5.2bn, as the Danish drugmaker looks to ...

RAPT Therapeutics, Inc. ( NASDAQ: RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria October 20, 2025 8:30 AM EDT Good morning, and welcome to RAPT's conference ...

After eight weeks of treatment, subcutaneous (SC) obexelimab triggered a 95% relative ... most commonly triggering mild injection site reactions, as well as infections and hypersensitivity. Investors ...

Anabolic therapies are currently administered by subcutaneous injection and used in a minority of eligible ... GlobalData is the parent company of Clinical Trials Arena. Give your business an edge ...